Marijke A Von Der Mohlen

Title: Marijke A Von Der Mohlen: Innovator in Therapeutic Protein Applications

Introduction

Marijke A Von Der Mohlen is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of therapeutic protein applications, particularly in the treatment of conditions related to bacterial endotoxin exposure. With a total of 3 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

One of her latest patents focuses on the human therapeutic uses of bactericidal/permeability-increasing (BPI) protein products. This patent discloses methods for treating humans who have been exposed to bacterial endotoxin in circulation. The administration of BPI protein products has been shown to result in serologically and hematologically verifiable alleviation of endotoxin-mediated increases in circulating cytokines, fibrinolysis, and coagulation factors. Additionally, changes in lymphocyte counts are observed upon such treatment. The patent also highlights the alleviation of endotoxin-mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).

Career Highlights

Throughout her career, Marijke has worked with notable organizations, including Xoma Corporation. Her innovative approaches and research have positioned her as a key figure in her field.

Collaborations

Marijke has collaborated with esteemed colleagues such as Nadav Friedmann and Patrick J Scannon. These partnerships have further enhanced her research and contributions to therapeutic applications.

Conclusion

Marijke A Von Der Mohlen is a trailblazer in the field of therapeutic protein applications, with a focus on addressing the challenges posed by bacterial endotoxin exposure. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.